Deferred Tax Assets, Valuation Allowance of Milestone Pharmaceuticals Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Milestone Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Milestone Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $89,353,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Milestone Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $89,353,000 +$9,138,000 +11% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $80,215,000 +$14,306,000 +22% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $65,909,000 +$12,387,000 +23% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $53,522,000 +$9,536,000 +22% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $43,986,000 +$12,720,000 +41% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q4 2019 $31,266,000 +$16,813,000 +116% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q4 2018 $14,453,000 31 Dec 2018 10-K/A 23 Oct 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.